Breeze J, Patel J, Dover M S, Williams R W
Queen Elizabeth Hospital Birmingham, Mindelsohn Way, Edgbaston, Birmingham B15 2GW.
Queen Elizabeth Hospital Birmingham, Mindelsohn Way, Edgbaston, Birmingham B15 2GW.
Br J Oral Maxillofac Surg. 2017 Oct;55(8):830-833. doi: 10.1016/j.bjoms.2017.08.001. Epub 2017 Aug 30.
Autogenous bone remains the gold standard for augmentation of the alveolar ridge in congenital hypodontia and appreciable post-traumatic deformity. This generally reflects the volume of material required for such defects and the osteogenic potential of the grafts. Morbidity at the donor site and success rates may lead to autogenous grafts being superseded by xenografts or alloplastic materials in the future, but we know of little evidence to confirm this. All patients having augmentation of the alveolar ridge or sinus lift to enable subsequent placement of implants between 01 January 2009 and 31 December 2016 were identified from a prospectively-gathered database held at the Queen Elizabeth Hospital, Birmingham. Morbidity was recorded, with overall success defined as a graft that enabled subsequent placement of an implant. During this period the following grafts: calvarial (n=4), iliac crest (n=4), and ramus (n=149) were recorded, as well as 53 sinus lifts. Sinus lift augmentation with BioOss had the highest success rate (51/53). Calvarial and iliac crest grafts had higher failure rates (2/4 and 3/4, respectively) than those from the mandibular ramus (6/149, 4%). Fifteen of 149 (10%) ramus grafts resulted in transient anaesthesia of the inferior alveolar nerve but no patients developed any permanent morbidity at the donor or recipient sites. Ramus grafts are a predictable method of bone augmentation with only transient morbidity at the donor site. Higher failure rates for extraoral grafts probably reflect their use in more challenging cases when more bone is required. Bilateral ramus grafts are an alternative to extraoral grafts and may be supplemented by bovine-derived particulate grafts with no appreciable increase in complications.
自体骨仍然是先天性缺牙和明显创伤后畸形中牙槽嵴增高的金标准。这通常反映了此类缺损所需材料的体积以及移植物的成骨潜力。供区的发病率和成功率可能导致自体移植物在未来被异种移植物或异质材料所取代,但我们几乎没有证据证实这一点。从伯明翰伊丽莎白女王医院前瞻性收集的数据库中识别出2009年1月1日至2016年12月31日期间所有接受牙槽嵴增高或上颌窦提升以利于后续种植体植入的患者。记录发病率,总体成功定义为能够使后续植入种植体的移植物。在此期间记录了以下移植物:颅骨(n = 4)、髂嵴(n = 4)和下颌支(n = 149),以及53例上颌窦提升。使用BioOss进行上颌窦提升增高的成功率最高(51/53)。颅骨和髂嵴移植物的失败率(分别为2/4和3/4)高于下颌支移植物(6/149,4%)。149例下颌支移植物中有15例(10%)导致下牙槽神经短暂麻醉,但没有患者在供区或受区出现任何永久性病变。下颌支移植物是一种可预测的骨增高方法,供区仅有短暂病变。口外移植物较高的失败率可能反映了它们在需要更多骨量的更具挑战性病例中的使用。双侧下颌支移植物是口外移植物的一种替代方法,并且可以用牛源颗粒移植物进行补充,而不会明显增加并发症。